3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
6
Sarcoma
5
Liposarcoma
4
Leiomyosarcoma
3
Neoplasms
2
Fallopian Tube Neoplasms
2
Sarcoma, Ewing
1
Recurrent High Grade Meningioma
1
Recurrence
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Liposarcoma, Myxoid
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
HhAntag691
2
toripalimab
1
temsirolimus
1
pegfilgrastim
1
pazopanib
1
liposomal doxorubicin
1
enasidenib
1
angiotensin I (1-7)
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Proton Therapy
1
Pharmacogenomic Testing
1
Microarray Analysis
1
Medicare Part B
1
Magnetic Resonance Spectroscopy
1
Immunologic Techniques
1
Gemcitabine
1
Filgrastim
1
Ferrosoferric Oxide
1
Fentanyl
1
Docetaxel
1
Dasatinib
1
Cyproheptadine
1
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chondrosarcoma
×
Trabectedin
×
Clear all
No trials found.